Stimwave Receives FDA Clearance For Opioid-Free Pain Management Wireless System

$ 19.50

4.8
(783)
In stock
Description

The new system gives patients iPhone and Apple Watch mobile control over WaveMaster multi-waveform automated programming.

Addressing Chronic Pain Amidst a National Opioid Crisis

Abstracts from the North American Neuromodulation Society's 2021

/Archives/edgar/data/1444380/0001564590

Drug-free, wireless pain relief from a medical device - Today's

FDA Clears Stimwave Miniature Peripheral Nerve Stimulator (PNS

Stimwave reveals 10 kHz Freedom stimulator SURF RCT results - NS

amanda, Author at NeuroNews International

High-Frequency vs Low-Frequency SCS Put to the Test in Study

Neural Stimulation – The World of Implantable Devices